Health

Results: 7105-7116 of 8689

PR Newswire associated0

Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories

Calliditas Therapeutics to Attend Investor Conferences in March

Ben Crosbie, CEO of The DRIPBaR and Sarah Lomas, Founder and CEO of REVIV Global, announce their exciting partnership. (Photo: Business Wire)

Wellness Market Leaders Join Forces: The DRIPBaR Powered by REVIV

iTeos to Participate in Upcoming Investor Conferences

PR Newswire associated0

Walden Group, one of the main players in European healthcare logistics, officially enters the Italian market

PR Newswire associated0

United Imaging Intelligence Unveiled Next-Generation Radiology Solutions at ECR 2024

Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients

GENESIS Pharma Announces an Exclusive Distribution Agreement With Regeneron Pharmaceuticals to Commercialize cemiplimab in Greece, Cyprus and Malta

'An Urgent Public Health Necessity' - National Institute for Play Releases New Report Underlining Science and Power of Play

STEMCELL Technologies is pleased to announce the acquisition of substantially all assets of SQZ Biotechnologies Company (SQZ)—a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them (mechanoporation) rather than using electricity (electroporation). This transaction, which was approved by SQZ shareholders on February 29, 2024, marks another significant milestone for STEMCELL, Canada’s largest biotechnology company. (Photo: Business Wire)

STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company

Sebia Receives U.S. FDA Clearance for the FLC Kappa & Lambda Assays

PR Newswire associated0

Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER